SARS-CoV-2 triggering autoimmune diseases

被引:61
|
作者
Mobasheri, Leila [1 ]
Nasirpour, Mohammad Hossein [2 ]
Masoumi, Elham [3 ,4 ]
Azarnaminy, Afsaneh Foolady [5 ]
Jafari, Mozhdeh [6 ,7 ]
Esmaeili, Seyed-Alireza [6 ,7 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Pharmacol, Mashhad, Razavi Khorasan, Iran
[2] Natl Inst Genet Engn & Biotechnol NIGEB, Inst Med Biotechnol, Dept Med Genet, Tehran, Iran
[3] Ilam Univ Med Sci, Sch Med, Dept Immunol, Ilam, Iran
[4] Ilam Univ Med Sci, Sch Med, Student Res Comm, Ilam, Iran
[5] Social Secur Org Hosp, Dept Anesthesiol, Ardebil, Iran
[6] Mashhad Univ Med Sci, Immunol Res Ctr, Mashhad, Razavi Khorasan, Iran
[7] Mashhad Univ Med Sci, Fac Med, Immunol Dept, Mashhad, Razavi Khorasan, Iran
关键词
SARS-CoV-2; Covid-19; Autoimmune disease; Autoimmunity; Cytokine; MOLECULAR MIMICRY; TOLEROGENIC PROBIOTICS; CLINICAL-FEATURES; MYASTHENIA-GRAVIS; T-CELLS; COVID-19; IMMUNOPATHOGENESIS; PATHOGENESIS; VACCINATION; EXPRESSION;
D O I
10.1016/j.cyto.2022.155873
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Autoimmunity, hyperstimulation of the immune system, can be caused by a variety of reasons. Viruses are thought to be important environmental elements that contribute to the development of autoimmune antibodies. It seems that viruses cause autoimmunity with mechanisms such as molecular mimicry, bystander activation of T cells, transient immunosuppression, and inflammation, which has also been seen in post-Covid-19 autoimmunity. Infection of respiratory epithelium by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates the immune response, triggers both innate and acquired immunity that led to the immune system's hyperactivation, excessive cytokine secretion known as "cytokine storm, " and finally acute respiratory distress syndrome (ARDS) associated with high mortality. Any factor in the body that triggers chronic inflammation can contribute to autoimmune disease, which has been documented during the Covid-19 pandemic. It has been observed that some patients produce autoantibody and autoreactive CD4(+) and CD8(+) T cells, leading to the loss of self-tolerance. However, there is a scarcity of evidence defining the precise molecular interaction between the virus and the immune system to elicit autoreactivity. Here, we present a review of the relevant immunological findings in Covid-19 and the current reports of autoimmune disease associated with the disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [11] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [12] SARS-COV-2 OUTBREAK IN AUTOIMMUNE DISEASES: THE EURO-COVIMID STUDY
    Saadoun, D.
    Vieira, M.
    Vautier, M.
    Baraliakos, X.
    Andreica, I.
    Da Silva, J. A. P.
    Sousa, M.
    Luis, M.
    Khmelinskii, N.
    Alvaro-Gracia, J. M.
    Castrejon, I.
    Nieto Gonzalez, J. C.
    Scire, C. A.
    Silvagni, E.
    Bortoluzzi, A.
    Penn, H.
    Hamdulay, S.
    Machado, P.
    Fautrel, B.
    Cacoub, P.
    Resche-Rigon, M.
    Gossec, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 233 - 234
  • [13] Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
    Di Altobrando, A.
    Patrizi, A.
    Bardazzi, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (07) : E295 - E297
  • [14] THE ROLE OF MOLECULAR MIMICRY IN SARS-COV-2 RELATED AUTOIMMUNE RHEUMATIC DISEASES
    Liaskos, C.
    Patrikiou, E.
    Komorowski, L.
    Tsigalou, C.
    Tsirogianni, A.
    Sakkas, L.
    Bogdanos, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1698 - 1698
  • [15] SARS-CoV-2 and gastrointestinal diseases
    Sha, Ailong
    Liu, Yi
    Zhao, Xuewen
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [16] SARS-CoV-2 and thyroid diseases
    Staruszkiewicz, Malgorzata
    Pituch-Noworolska, Anna
    Skoczen, Szymon
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2023, 7
  • [17] SARS-CoV-2 in neurodegenerative diseases
    Aranda-Abreu, Gonzalo Emiliano
    Carreon-Rodriguez, Alfonso
    Zuniga, Sonia
    Pozo, David
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [18] Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    Cheng, Qi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 62 - 83
  • [19] Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases
    Teng, Jialin
    Dai, Jin
    Su, Yutong
    Zhou, Zhuochao
    Chi, Huihui
    Wan, Liyan
    Meng, Jianfen
    Wang, Zhihong
    Wang, Fan
    Ma, Yuning
    Hu, Qiongyi
    Cheng, Xiaobing
    Liu, Honglei
    Ye, Junna
    Shi, Hui
    Sun, Yue
    Yang, Chengde
    Wang, Xuefeng
    LANCET RHEUMATOLOGY, 2020, 2 (07): : E384 - E385
  • [20] Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
    Sanket Shah
    Debashish Danda
    Chengappa Kavadichanda
    Saibal Das
    M. B. Adarsh
    Vir Singh Negi
    Rheumatology International, 2020, 40 : 1539 - 1554